| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6566979
[patent_doc_number] => 20020165123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'CXCR4 agonist treatment of hemapoietic cells'
[patent_app_type] => new
[patent_app_number] => 09/835107
[patent_app_country] => US
[patent_app_date] => 2001-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18523
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165123.pdf
[firstpage_image] =>[orig_patent_app_number] => 09835107
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/835107 | CXCR4 agonist treatment of hemapoietic cells | Apr 11, 2001 | Abandoned |
| 09/743416 | Treatment of celiac disease with interleukin-15 antagonists | Apr 10, 2001 | Abandoned |
Array
(
[id] => 1306003
[patent_doc_number] => 06617131
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-09
[patent_title] => 'Nucleic acid molecule encoding the potassium channel protein, KCNQ5'
[patent_app_type] => B2
[patent_app_number] => 09/813148
[patent_app_country] => US
[patent_app_date] => 2001-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19388
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/617/06617131.pdf
[firstpage_image] =>[orig_patent_app_number] => 09813148
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/813148 | Nucleic acid molecule encoding the potassium channel protein, KCNQ5 | Mar 20, 2001 | Issued |
Array
(
[id] => 719673
[patent_doc_number] => 07049137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'KCNQ5, a novel potassium channel'
[patent_app_type] => utility
[patent_app_number] => 09/810796
[patent_app_country] => US
[patent_app_date] => 2001-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 23985
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049137.pdf
[firstpage_image] =>[orig_patent_app_number] => 09810796
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/810796 | KCNQ5, a novel potassium channel | Mar 14, 2001 | Issued |
Array
(
[id] => 5888515
[patent_doc_number] => 20020012953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'Methods for separation and isolation of subpopulations of cells in biological samples'
[patent_app_type] => new
[patent_app_number] => 09/804972
[patent_app_country] => US
[patent_app_date] => 2001-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14123
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20020012953.pdf
[firstpage_image] =>[orig_patent_app_number] => 09804972
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/804972 | Methods for separation and isolation of subpopulations of cells in biological samples | Mar 12, 2001 | Abandoned |
Array
(
[id] => 5844303
[patent_doc_number] => 20020132292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'NUCLEIC ACID MOLECULES ENCODING HUMAN TRANSPORTER PROTEINS'
[patent_app_type] => new
[patent_app_number] => 09/803661
[patent_app_country] => US
[patent_app_date] => 2001-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 23796
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132292.pdf
[firstpage_image] =>[orig_patent_app_number] => 09803661
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/803661 | NUCLEIC ACID MOLECULES ENCODING HUMAN TRANSPORTER PROTEINS | Mar 11, 2001 | Abandoned |
Array
(
[id] => 6141611
[patent_doc_number] => 20020001828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-03
[patent_title] => 'Chemokine-like factors (CKLFs) with chemotactic and hematopoietic stimulating activities'
[patent_app_type] => new
[patent_app_number] => 09/801115
[patent_app_country] => US
[patent_app_date] => 2001-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13474
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20020001828.pdf
[firstpage_image] =>[orig_patent_app_number] => 09801115
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/801115 | Nucleic acid molecule encoding chemokine-like factor 1 (CKLF1) | Mar 6, 2001 | Issued |
Array
(
[id] => 686514
[patent_doc_number] => 07078230
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-18
[patent_title] => 'Adipose tissue-derived stromal cell that expresses characteristics of a neuronal cell'
[patent_app_type] => utility
[patent_app_number] => 09/793173
[patent_app_country] => US
[patent_app_date] => 2001-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9795
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/078/07078230.pdf
[firstpage_image] =>[orig_patent_app_number] => 09793173
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/793173 | Adipose tissue-derived stromal cell that expresses characteristics of a neuronal cell | Feb 25, 2001 | Issued |
Array
(
[id] => 7226594
[patent_doc_number] => 20050261487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Dna molecules encoding ligand-gated ion channels from drosophila melanogaster'
[patent_app_type] => utility
[patent_app_number] => 10/204029
[patent_app_country] => US
[patent_app_date] => 2001-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19243
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20050261487.pdf
[firstpage_image] =>[orig_patent_app_number] => 10204029
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/204029 | DNA molecules encoding ligand-gated ion channels from Drosophila melanogaster | Feb 25, 2001 | Issued |
| 09/623304 | Identification and expression of human kir5.1 | Feb 20, 2001 | Abandoned |
Array
(
[id] => 6142176
[patent_doc_number] => 20020002132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-03
[patent_title] => 'Use of interleukin-4 antagonists and compositions thereof'
[patent_app_type] => new
[patent_app_number] => 09/785934
[patent_app_country] => US
[patent_app_date] => 2001-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20424
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20020002132.pdf
[firstpage_image] =>[orig_patent_app_number] => 09785934
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/785934 | Use of interleukin-4 antagonists and compositions thereof | Feb 14, 2001 | Abandoned |
| 09/783131 | NUCLEIC ACID MOLECULES ENCODING HUMAN TRANSPORTER PROTEINS | Feb 14, 2001 | Abandoned |
Array
(
[id] => 6082155
[patent_doc_number] => 20020082191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/776705
[patent_app_country] => US
[patent_app_date] => 2001-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 23865
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082191.pdf
[firstpage_image] =>[orig_patent_app_number] => 09776705
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/776705 | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | Feb 5, 2001 | Abandoned |
Array
(
[id] => 689888
[patent_doc_number] => 07074402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-11
[patent_title] => 'Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC)'
[patent_app_type] => utility
[patent_app_number] => 09/777484
[patent_app_country] => US
[patent_app_date] => 2001-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 20
[patent_no_of_words] => 12759
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/074/07074402.pdf
[firstpage_image] =>[orig_patent_app_number] => 09777484
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/777484 | Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC) | Feb 4, 2001 | Issued |
Array
(
[id] => 1068788
[patent_doc_number] => 06844314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-18
[patent_title] => 'Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy'
[patent_app_type] => utility
[patent_app_number] => 09/765644
[patent_app_country] => US
[patent_app_date] => 2001-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 21
[patent_no_of_words] => 24246
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/844/06844314.pdf
[firstpage_image] =>[orig_patent_app_number] => 09765644
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/765644 | Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy | Jan 21, 2001 | Issued |
Array
(
[id] => 6408019
[patent_doc_number] => 20020037848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy'
[patent_app_type] => new
[patent_app_number] => 09/765301
[patent_app_country] => US
[patent_app_date] => 2001-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 24470
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037848.pdf
[firstpage_image] =>[orig_patent_app_number] => 09765301
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/765301 | Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy | Jan 21, 2001 | Abandoned |
Array
(
[id] => 1256709
[patent_doc_number] => 06667391
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-23
[patent_title] => 'Stem cell growth factor-like polypeptide'
[patent_app_type] => B1
[patent_app_number] => 09/764325
[patent_app_country] => US
[patent_app_date] => 2001-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 43859
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/667/06667391.pdf
[firstpage_image] =>[orig_patent_app_number] => 09764325
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/764325 | Stem cell growth factor-like polypeptide | Jan 15, 2001 | Issued |
Array
(
[id] => 6624599
[patent_doc_number] => 20020065405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Novel polypeptides and nucleic acids encoding same'
[patent_app_type] => new
[patent_app_number] => 09/761288
[patent_app_country] => US
[patent_app_date] => 2001-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45150
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065405.pdf
[firstpage_image] =>[orig_patent_app_number] => 09761288
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/761288 | Novel polypeptides and nucleic acids encoding same | Jan 15, 2001 | Abandoned |
Array
(
[id] => 7094040
[patent_doc_number] => 20010034438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-25
[patent_title] => 'Novel human membrane protein and polynucleotides encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/755017
[patent_app_country] => US
[patent_app_date] => 2001-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18458
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20010034438.pdf
[firstpage_image] =>[orig_patent_app_number] => 09755017
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/755017 | Novel human membrane protein and polynucleotides encoding the same | Jan 4, 2001 | Abandoned |
Array
(
[id] => 5859008
[patent_doc_number] => 20020123091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Novel inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization'
[patent_app_type] => new
[patent_app_number] => 09/742201
[patent_app_country] => US
[patent_app_date] => 2000-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 55233
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123091.pdf
[firstpage_image] =>[orig_patent_app_number] => 09742201
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/742201 | Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor | Dec 18, 2000 | Issued |